Please assess the completion status of the following clinical trial:

Trial Title: Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of panic disorder, with or without agoraphobia according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, text revision (DSM-IV-TR) criteria, as determined by a structured clinical interview.~* At least two panic attacks in the week preceding their inclusion in the study.~Exclusion Criteria:~* Patients unable or unwilling to provide written informed consent.~* Did not complete all the evaluations before study initiation.~* Had comorbidities that could affect clinical evaluation including drug abuse, neurological disorders, or severe personality disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Clonazepam (Type: ACTIVE_COMPARATOR): Treatment with clonazepam
- Paroxetine (Type: ACTIVE_COMPARATOR): Treatment with paroxetine

Based on this trial design, predict the completion outcome and termination type (if applicable).